PHAT - Phathom Pharmaceuticals GAAP EPS of -$0.84 beats by $0.14 August, 10 2023 12:23 PM Phathom Pharmaceuticals Inc. 2023-08-10 12:23:37 ET Phathom Pharmaceuticals press release ( NASDAQ: PHAT ): Q2 GAAP EPS of -$0.84 beats by $0.14 . As of June 30, 2023, cash and cash equivalents were $248.8 million. For further details see: Phathom Pharmaceuticals GAAP EPS of -$0.84 beats by $0.14